e , complete elimination of aggressive, orthotopic pancreatic can

e., complete elimination of aggressive, orthotopic pancreatic cancers after

5 iv injections administered once a week. At best, the receptor-targeted nanocomplex (RTN) with endosomally cleavable PEG and RGD integrin-targeting peptide showed only a 2-fold increased delivery to subcutaneous neuroblastoma tumors [11]. Furthermore, only a 75% reduction in tumor size after 7 iv injections administered every 48h was achieved using this optimized formulation. Targeted delivery systems can also be less efficient in delivery to the target compared to the non-PEGylated, nontargeted formulations as shown for #selleck catalog keyword# the MEND system (Table 1) [12, 13, 32]. Not surprising, no efficacy in Inhibitors,research,lifescience,medical any disease model has been reported for this delivery system. In summary, we have www.selleckchem.com/products/VX-770.html defined and distinguished our novel reversible masking versus PEGylation and demonstrated its superior use for avoiding nonspecific uptake in vivo. Abbreviations BIV: Bilamellar invaginated vesicle NP: Nanoparticle Iv: Intravenous RM: Reversible masking.
Collagen is a major connective tissue protein that plays an important Inhibitors,research,lifescience,medical role in the extracellular matrix in animals. As such, collagen possesses good biocompatibility with animal body

tissues [1]. Atelocollagen is a type of soluble collagen produced from tropocollagen, the collagen molecule that makes up collagen fibrils, via the elimination of the telopeptide moieties, which are considered to account for most of collagen’s antigenicity [1, 2]. Thus, atelocollagen is considered to have little immunogenicity, which makes it a safe biomaterial [1]. In fact, it is widely used for implantable medical and plastic surgical products Inhibitors,research,lifescience,medical [1]. Atelocollagen is also used as a drug delivery carrier. For

example, a minipellet atelocollagen formulation has been demonstrated to sustain the release and maintain stable blood concentrations of protein drugs for more than 1 week [2]. Many kinds of protein drugs such as interferon-α [3], interleukin-2 [4], nerve growth factor [5], and bone morphogenetic protein [6], and so forth, have been administered Inhibitors,research,lifescience,medical using AV-951 this drug delivery system, and interferon-α and interleukin-2 showed strong antitumor activities in animal models when administered in this manner [3, 4]. In the past decade, as well as being used as a solid substrate, dissolved atelocollagen has been used as a drug delivery vehicle for nucleic acid-based medicines for gene conversion [7], inflammatory disease [8, 9], and tumor therapy. Atelocollagen can be used to deliver most kinds of nucleic acid-based medicines including plasmid DNA [10], antisense oligodeoxynucleotides (ODN) [11–13], short interference RNA (siRNA) [14–20], and micro RNA (miRNA) [21–23]. It is also capable of delivering oligonucleotides to subcutaneous xenografts and metastatic tumors after its local and/or systemic administration.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>